Laboratory Considerations for Clinical Trials
Science:Life Sciences
With fewer people covering more roles with less specialization and novel therapeutics with unique testing requirements, the needs of small biotech companies in clinical trials are different from larger sponsors.
In this episode, Alex Watt, Global Head for Biotech Integrated Laboratory Solutions and Mona Henderson, Director of Laboratory Network Solutions (both at Q2 Solutions) discuss how our dedicated biotech teams focus specifically on the unique needs of those customers.
Alex and Mona cover:
- Operational strategy, from supply chain to data management
- The role of LNS in contracting and managing specialty, third-party labs
- Collaboration with our parent company, IQVIA and
- Adapting to evolving customer strategies
You can learn more at https://q2labsolutions.com/biotech.
More Episodes
What is the Role of Digital Pathology in Clinical Trials
2023-11-17
264
2023-11-17
264
Risk Management for Biotech Companies in Clinical Trials
2022-05-16
238
2022-05-16
238
Managing Sample Data from Vendors
2021-09-14
268
2021-09-14
268
Automation within an ADME Laboratory
2021-08-26
221
2021-08-26
221
Bioanalytical Automation of Samples
2021-07-30
197
2021-07-30
197
Consent Tracking for Clinical Samples
2021-07-28
200
2021-07-28
200
Tracking Clinical Trial Samples
2021-07-28
193
2021-07-28
193
Avoiding Canceled Tests in Pediatric Samples
2021-02-02
157
2021-02-02
157
Covid Vaccine Testing
2020-09-15
205
2020-09-15
205
Hybrid Assays for Protein Bioanalysis
2020-07-29
169
2020-07-29
169
High Throughput ADME Testing
2020-07-29
114
2020-07-29
114
Liquid Biopsy Collection in Clinical Development Programs
2020-07-29
157
2020-07-29
157
Get this podcast on your
phone, FREE
